Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-028975

Director sold 26,000 shares at $36.54 ($950,040)

From the SEC's structured data for this filing

Trades in this filing

Waddill William D. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-05-11 Sale : show line 1 in the form −26,000 $36.54 $950,040 28,000 D
Open-market sales · 26,000 sh · avg $36.54 · $950,040
Loading xslF345X03/doc4.xml…